'Pan-RAS molecular glue' is a safe and effective treatment for lung… | HappeningNow.news

Health · 9 views

'Pan-RAS molecular glue' is a safe and effective treatment for lung and pancreatic cancers

Results from the AURORAS-1 Phase I clinical trial of an anticancer drug called ERAS-0015 have shown that it is safe and has caused tumors to shrink in hard-to-treat diseases such as lung and pancreatic cancer.

Source AI Summary Published 1h 08m ago Brief Under 1 min brief
Story intelligence
Coverage Single outlet Single-outlet story
Views 9 Community interest
Brief read Under 1 min brief 79 words

AI Summary

The Phase I AURORAS‑1 trial of ERAS‑0015, an anticancer drug, showed the treatment is safe and produced tumor shrinkage in patients with hard‑to‑treat lung and pancreatic cancers. The study enrolled 148 patients and was presented at the 38th EORTC‑NCI‑AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain. ERAS‑0015 specifically targets tumors driven by mutations in the RAS gene, a target previously considered difficult to drug. The results suggest that designing drugs against RAS mutations is now feasible.

AI summaries can be wrong sometimes—always verify important details using the source article.

How AI & Automation are used
Read original at Medical Xpress

Coverage Context

Part of RAS coverage 6 tracked stories

More from Health

Continue reading recent Health coverage

Support HappeningNow

Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.

Support HappeningNow

Report an issue with this page